Search Results 171-180 of 17510 for metformin

1. A Study To Evaluate The Safety And Effectiveness Of The Drug TTP399 To Target A1c In Type 2 Diabetics - Mayo Clinic

   On a stable (for the last 3 months prior to screening) regimen of metformin monotherapy equivalent of at least 1000 mg once daily. Males, females of ...

2. Importance of pre-pregnancy care for women with diabetes: A case from the endocrine teaching clinics

   With the exception of metformin and insulin, all glucose-lowering agents should be discontinued. Previously, NPH insulin and regular insulin were typically ...

3. Investigational Extended Wear Insulin Infusion Set During Home Use for Type 1 Diabetes - Mayo Clinic

   Concurrent use of any non-insulin glucose-lowering agent, other than metformin (for example, GLP-1 agonists, Symlin, DPP-4 inhibitors, SGLT-2 inhibitors, ...

4. Pioglitazone Versus Empagliflozin For Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus - Mayo Clinic

   * Fasting plasma glucose <220 mg/dL at screening visit. * Not on any antihyperglycemic medication except Metformin * Willing to perform blood glucose and ...

5. The International Diabetes Closed Loop Trial DCLP4 - Mayo Clinic

   Use of Afrezza or any non-insulin glucose-lowering agent other than metformin (including GLP-1 agonists, DPP-4 inhibitors, SGLT-2 inhibitors, sulfonylureas) ...

6. A Study of How Common Bile Acid Malabsorption is in Patients with Diarrhea Predominant Irritable Bowel Syndrome - Mayo Clinic

   Participation eligibility · Birth control pill, estrogen replacement therapy, metformin and thyroxine replacement are permissible exceptions · Agents that alter ...

7. Liraglutide (subcutaneous route) - Side effects & dosage - Mayo Clinic

   However, low blood sugar can occur when you use liraglutide with other medicines that can lower blood sugar, such as insulin, metformin, or a sulfonylurea.

8. An inconspicuous pheochromocytoma: A case from the endocrine teaching clinics

   ... metformin. Medications were titrated to achieve optimal blood pressure, blood glucose and lipid control. He was on six new medications, including two ...

9. A Study To Explore The Renal Safety Of Visipaque Injection 320 MgI/mL In Patients With Chronic Kidney Disease - Mayo Clinic

   ... metformin is resumed). Has been exposed to any intravascular iodinated contrast medium in the 7 14 days prior to the Baseline Visit. Has congestive heart ...

10. Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes (REVITALIZE 1) - Mayo Clinic

    * Metformin, * GLP-1 RA including dual peptide agonists and related molecules (e.g., GLP-1/GIP RA), * DPP-4i, * TZDs, * SGLT2is, * SUs, * Meglitinides ...